These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
148 related items for PubMed ID: 18445617
1. Effect of antihypertensive therapy on serum lipids in newly diagnosed essential hypertensive men. Nandeesha H, Pavithran P, Madanmohan T. Angiology; 2009; 60(2):217-20. PubMed ID: 18445617 [Abstract] [Full Text] [Related]
2. Antihypertensive drugs and blood lipids: the Oslo study. Leren P, Eide I, Foss OP, Helgeland A, Hjermann I, Holme I, Kjeldsen SE, Lund-Larsen PG. J Cardiovasc Pharmacol; 1982; 4 Suppl 2():S222-4. PubMed ID: 6177960 [Abstract] [Full Text] [Related]
3. Single-pill amlodipine/atorvastatin helps patients of diverse ethnicity attain recommended goals for blood pressure and lipids (the Gemini-AALA study). Erdine S, Ro YM, Tse HF, Howes LG, Aguilar-Salinas CA, Chaves H, Guindy R, Chopra P, Moller RA, Schou IM, Gemini-AALA Investigators. J Hum Hypertens; 2009 Mar; 23(3):196-210. PubMed ID: 18800143 [Abstract] [Full Text] [Related]
4. Effect of antihypertensive therapy on plasma lipids and lipoproteins in mild hypertension. Sagar S, Majumdar S, Sharma BK. Indian Heart J; 1989 Mar; 41(1):39-50. PubMed ID: 2737688 [Abstract] [Full Text] [Related]
5. Effects of moduretic on plasma lipid and lipoprotein levels in hypertensive African patients. Ahaneku JE, Taylor GO, Agbedana OE, Walker O, Salako LA. Tokai J Exp Clin Med; 1993 Dec; 18(3-6):155-60. PubMed ID: 7701530 [Abstract] [Full Text] [Related]
7. Comparative effects of atenolol versus nifedipine on serum lipids and other biochemical parameters in diabetic and non-diabetic hypertensive subjects. Satia MC, Shukla ML, Goyal RK. Indian J Physiol Pharmacol; 1995 Jul; 39(3):237-41. PubMed ID: 8550116 [Abstract] [Full Text] [Related]
8. Effects of losartan compared with atenolol on lipids in patients with hypertension and left ventricular hypertrophy: the Losartan Intervention For Endpoint reduction in hypertension study. Olsen MH, Wachtell K, Beevers G, Dahlöf B, de Simone G, Devereux RB, de Faire U, Fyhrquist F, Ibsen H, Kjeldsen SE, Lederballe-Pedersen O, Lindholm LH, Lyle PA, Nieminen MS, Omvik P, Oparil S, Wedel H. J Hypertens; 2009 Mar; 27(3):567-74. PubMed ID: 19262226 [Abstract] [Full Text] [Related]
9. Serum lipoprotein profile under different antihypertensive therapy. Youssef S, Osman L, Sabbour MS. Int J Clin Pharmacol Res; 1992 Mar; 12(3):109-16. PubMed ID: 1473876 [Abstract] [Full Text] [Related]
10. Effect of antihypertensive drug therapy on short-term heart rate variability in newly diagnosed essential hypertension. Pavithran P, Prakash ES, Dutta TK, Madanmohan T. Clin Exp Pharmacol Physiol; 2010 Feb; 37(2):e107-13. PubMed ID: 19769606 [Abstract] [Full Text] [Related]
11. Switching fibrate to statin in type 2 diabetic patients: consequences on lipid profile. Meas T, Laloi-Michelin M, Virally M, Peynet J, Giraudeaux V, Kévorkian JP, Guillausseau PJ. Eur J Intern Med; 2009 Mar; 20(2):197-200. PubMed ID: 19327612 [Abstract] [Full Text] [Related]
12. Disturbed lipids, lipoproteins and triglyceride-rich lipoproteins as well as fasting and nonfasting non-high-density lipoprotein cholesterol in post-renal transplant patients. Kimak E, Ksiazek A, Baranowicz-Gaszczyk I, Solski J. Ren Fail; 2007 Mar; 29(6):705-12. PubMed ID: 17763166 [Abstract] [Full Text] [Related]
13. Effect of isradipine, a new calcium antagonist on the lipid profile in patients with hypertension. Samuel P. Cor Vasa; 1990 Mar; 32(2 Suppl 1):35-41. PubMed ID: 2143459 [Abstract] [Full Text] [Related]
14. Lipid profile cutoff values for predicting hypertension in an Iranian population (ROC curve analysis). Chehrei A, Sadrnia S, Samanianpour P, Soltani P, Mashayekhim N, Fani A. Med Sci Monit; 2007 Feb; 13(2):CR100-4. PubMed ID: 17261981 [Abstract] [Full Text] [Related]
15. Long-term effects of diltiazem and atenolol on blood glucose, serum lipids, and serum urate in hypertensive patients. Swedish-Finnish Study Group. Thulin T, Lehtonen A, Dahlöf C, Nilsson-Ehle P, Engqvist L, Lagerstedt C, Berglund E. Int J Clin Pharmacol Ther; 1999 Jan; 37(1):28-33. PubMed ID: 10027480 [Abstract] [Full Text] [Related]
16. Effects of different antihypertensive drugs on plasma fibrinogen in hypertensive patients. Fogari R, Zoppi A, Malamani GD, Marasi G, Vanasia A, Villa G. Br J Clin Pharmacol; 1995 May; 39(5):471-6. PubMed ID: 7669481 [Abstract] [Full Text] [Related]
17. Effect of beta-blockers on plasma lipids. Pasotti C, Zoppi A, Capra A, Rebagliati M, Fogari R. Int J Clin Pharmacol Ther Toxicol; 1986 Aug; 24(8):448-52. PubMed ID: 3759280 [Abstract] [Full Text] [Related]
18. Clinical effectiveness of low-dose chlorthalidone (6.25 mg) + atenolol combination in stage I hypertensive patients: a multicenter, randomized, controlled study. Pareek A, Karnik N, Salagre SB, Zawar SD, Joglekar VK, Chandurkar N, Naik GS. Curr Med Res Opin; 2008 Jun; 24(6):1771-9. PubMed ID: 18479589 [Abstract] [Full Text] [Related]
19. Serum lipid profile in malnourished Nigerian children in Zaria. Akuyam A, Isah HS, Ogala WN. Niger Postgrad Med J; 2008 Sep; 15(3):192-6. PubMed ID: 18923595 [Abstract] [Full Text] [Related]
20. Changes in lipid and lipoprotein values during a cross-over treatment of doxazosin, moduretic and amlodipine in hypertensive patients. Ahaneku JE, Taylor GO, Agbedana EO, Walker O, Salako LA. J Pak Med Assoc; 1994 Jul; 44(7):166-9. PubMed ID: 7933456 [Abstract] [Full Text] [Related] Page: [Next] [New Search]